Financial Information Show all 2020 Q4 Syndax Pharmaceuticals Reports Fourth Quarter 2020 Financial Results and Provides Clinical and Business Update Syndax Fourth Quarter 2020 Conference Call Form 10-K Proxy Statements Filing date View 04.01.21 View HTML 0001564590-21-017347.pdf 0001564590-21-017347.xls Form 10-K Filing date View 03.12.21 View HTML 0001564590-21-012607.pdf 0001564590-21-012607.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q Filing date View 11.05.20 View HTML 0001564590-20-051287.pdf 0001564590-20-051287.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA 08.06.20 View HTML 0001564590-20-037777.pdf 0001564590-20-037777.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
